Janus Henderson Group PLC Protara Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,102,620 shares of TARA stock, worth $22.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,102,620
Previous 3,788,176
8.3%
Holding current value
$22.2 Million
Previous $16.1 Million
22.97%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TARA
# of Institutions
86Shares Held
28.1MCall Options Held
37.2KPut Options Held
65.1K-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$11.6 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$10.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$9.73 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$9.46 Million3.47% of portfolio
-
Catalio Capital Management, LP New York, NY1.63MShares$8.78 Million1.03% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $60.8M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...